Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP113500.RA_FTBYh-Qt4gkghbEUNTfF6ocbeErJBZiuiL54-YIiCA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP113500.RA_FTBYh-Qt4gkghbEUNTfF6ocbeErJBZiuiL54-YIiCA130_assertion type Assertion NP113500.RA_FTBYh-Qt4gkghbEUNTfF6ocbeErJBZiuiL54-YIiCA130_head.
- NP113500.RA_FTBYh-Qt4gkghbEUNTfF6ocbeErJBZiuiL54-YIiCA130_assertion description "[CXCR4 is expressed in human ductal carcinoma in situ as well as in atypical ductal hyperplasia; expression at this early step of tumor development suggests CXCR4 role in providing selective advantage to such cells on their way to metastasizing carcinomas ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP113500.RA_FTBYh-Qt4gkghbEUNTfF6ocbeErJBZiuiL54-YIiCA130_provenance.
- NP113500.RA_FTBYh-Qt4gkghbEUNTfF6ocbeErJBZiuiL54-YIiCA130_assertion evidence source_evidence_literature NP113500.RA_FTBYh-Qt4gkghbEUNTfF6ocbeErJBZiuiL54-YIiCA130_provenance.
- NP113500.RA_FTBYh-Qt4gkghbEUNTfF6ocbeErJBZiuiL54-YIiCA130_assertion SIO_000772 15026622 NP113500.RA_FTBYh-Qt4gkghbEUNTfF6ocbeErJBZiuiL54-YIiCA130_provenance.
- NP113500.RA_FTBYh-Qt4gkghbEUNTfF6ocbeErJBZiuiL54-YIiCA130_assertion wasDerivedFrom lhgdn-20090331 NP113500.RA_FTBYh-Qt4gkghbEUNTfF6ocbeErJBZiuiL54-YIiCA130_provenance.
- NP113500.RA_FTBYh-Qt4gkghbEUNTfF6ocbeErJBZiuiL54-YIiCA130_assertion wasGeneratedBy ECO_0000203 NP113500.RA_FTBYh-Qt4gkghbEUNTfF6ocbeErJBZiuiL54-YIiCA130_provenance.